SARS-CoV-2 infection Trials in Dallas, United States
Conditions / SARS-CoV-2 infection / Dallas, United States
Clinical trials for SARS-CoV-2 infection investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | COMPLETED | PHASE2/PHASE3 |
| NCT04754594 | To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older | COMPLETED | PHASE2/PHASE3 |
| NCT05997290 | A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals | COMPLETED | — |
| NCT05384899 | Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol | COMPLETED | — |
| NCT05897541 | Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection | COMPLETED | PHASE3 |
| NCT04955626 | To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. | COMPLETED | PHASE3 |
| NCT07300839 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | RECRUITING | PHASE3 |
| NCT04636697 | Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT06063330 | Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects | COMPLETED | PHASE1 |
| NCT05004181 | Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants | COMPLETED | PHASE2 |